Design of a Phase 2a Study to Evaluate the Safety, Efficacy, and Tolerability of Intravenous Empasiprubart as an Add-On Therapy to Intravenous Efgartigimod in Adult Participants With Generalized Myasthenia Gravis

The Relationship Between Diagnostic Delay and Rates of Anxiety and Depression in Patients Living With Amyotrophic Lateral Sclerosis (plwALS)

Cerebrospinal Fluid CHI3L2 as a Biomarker for Amyotrophic Lateral Sclerosis and Predicts Faster Disability Progression